Dr Bruce Levine of the University of Pennsylvania will receive the Genome Valley Excellence Award 2026 at BioAsia for his groundbreaking work in cell and gene therapy, particularly CAR T-cell treatments for cancer. His innovations have significantly advanced personalized medicine and cancer immunotherapy, setting new benchmarks for translational research and global healthcare.